XML 43 R75.htm IDEA: XBRL DOCUMENT v2.4.0.8
POSTRETIREMENT MEDICAL BENEFITS Pneumoconiosis (Black Lung) Benefit Obligation (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Pneumoconiosis Benefit Obligation [Abstract]    
Net benefit obligation at end of year $ 158,700 $ 176,500
Pneumoconiosis (Black Lung) Benefits [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Net benefit obligation at end of year 14,143 16,200
Plan assets at fair value, primarily government-backed securities 5,468 7,844
Unfunded status at end of year 8,675 8,356
Rate used to determine benefit obligations as of the end of the year shown 4.00% 3.25%
Pneumoconiosis (Black Lung) Benefits [Member] | Fair Value [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 5,468 7,844
Pneumoconiosis (Black Lung) Benefits [Member] | Quoted prices in active markets for identical assets - Level 1 [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 3 27
Pneumoconiosis (Black Lung) Benefits [Member] | Significant other observable inputs - Level 2 [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 5,465 7,817
Pneumoconiosis (Black Lung) Benefits [Member] | US Treasury Securities [Member] | Fair Value [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 5,280 7,548
Pneumoconiosis (Black Lung) Benefits [Member] | US Treasury Securities [Member] | Quoted prices in active markets for identical assets - Level 1 [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 0 0
Pneumoconiosis (Black Lung) Benefits [Member] | US Treasury Securities [Member] | Significant other observable inputs - Level 2 [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 5,280 7,548
Pneumoconiosis (Black Lung) Benefits [Member] | Collateralized Mortgage Backed Securities [Member] | Fair Value [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 185 269
Pneumoconiosis (Black Lung) Benefits [Member] | Collateralized Mortgage Backed Securities [Member] | Quoted prices in active markets for identical assets - Level 1 [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 0 0
Pneumoconiosis (Black Lung) Benefits [Member] | Collateralized Mortgage Backed Securities [Member] | Significant other observable inputs - Level 2 [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 185 269
Pneumoconiosis (Black Lung) Benefits [Member] | Cash and cash equivalents | Fair Value [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 3 27
Pneumoconiosis (Black Lung) Benefits [Member] | Cash and cash equivalents | Quoted prices in active markets for identical assets - Level 1 [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 3 27
Pneumoconiosis (Black Lung) Benefits [Member] | Cash and cash equivalents | Significant other observable inputs - Level 2 [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Trust assets 0 0
Terminated Employees [Member] | Pneumoconiosis (Black Lung) Benefits [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Net benefit obligation at end of year 876 1,139
Existing Claimants [Member] | Pneumoconiosis (Black Lung) Benefits [Member]
   
Pneumoconiosis Benefit Obligation [Abstract]    
Net benefit obligation at end of year $ 13,267 $ 15,061